AMAG Pharma (AMAG) Income Statement

Click line-items for a historical chart and %

Revenues:
Product sales, net	115.78M
License fee and other collaboration revenues	40K
Royalties
Total revenues	143.78M
Costs and expenses:
Cost of product sales	25.71M
Research and development expenses	17.12M
Selling, general and administrative expenses	57.22M
Total costs and expenses	105.02M
Other income (expense):
Interest and dividend income, net
(Losses) gains on investments, net
Fair value adjustment of settlement rights
Total other income (expense)
Net loss before income taxes	21.27M
Income tax benefit
Net loss
Net loss per share:
Basic and diluted (in dollars per share)
Weighted average shares outstanding used to compute net loss per share:
Basic (in shares)	34.17M
Diluted (in shares)	42.11M

Entities mentioned with AMAG